The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 18061443 |
34 |
Alpha-hydroxy amides as a novel class of bradykinin B1 selective antagonists. |
Merck Research Laboratories |
| 22088753 |
44 |
Chromenones as potent bradykinin B1 antagonists. |
Amgen |
| 21902230 |
49 |
Discovery of potent, orally bioavailable phthalazinone bradykinin B1 receptor antagonists. |
Amgen |
| 20369879 |
21 |
Bradykinin B1 receptor antagonists as potential therapeutic agents for pain. |
Johnson & Johnson Pharmaceutical Research and Development |
| 18706809 |
45 |
Aryl sulfones as novel bradykinin B1 receptor antagonists for treatment of chronic pain. |
Amgen |
| 17408249 |
76 |
Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides. |
Amgen |
| 17243660 |
42 |
Identification of a nonpeptidic and conformationally restricted bradykinin B1 receptor antagonist with anti-inflammatory activity. |
Amgen |
| 17228869 |
44 |
Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists. |
Merck Research Laboratories |
| 15588075 |
33 |
2,3-diaminopyridine bradykinin B1 receptor antagonists. |
Merck Research Laboratories |
| 15546726 |
22 |
Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studies. |
Merck Research Laboratories |
Search and Browse
